| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/30/2006 | CN1272002C Supermolecular intercalation-structure slow-release captopril and its preparing method |
| 08/30/2006 | CN1272001C Aniracetam drop pills |
| 08/30/2006 | CN1272000C Troxerutin-coumarin dripping pill |
| 08/30/2006 | CN1271998C An anti-cataract medicine |
| 08/30/2006 | CN1271997C Oral disintegration tablets contg. p-acetaminophenol, and prepn. method therefor |
| 08/30/2006 | CN1271996C Medicinal powder injection for respiratory system and preparing method |
| 08/30/2006 | CN1271995C Orally disintegrating tablet of 'Xintongning' and its preparation |
| 08/30/2006 | CN1271994C Compound Chinese angelica root freeze-dried powder injection and its preparing method |
| 08/30/2006 | CN1271993C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
| 08/30/2006 | CN1271992C Cationic virosomes as transfer system for genetic material |
| 08/29/2006 | US7099713 Skin conduction and transport systems |
| 08/29/2006 | US7098305 Sustained release of microcrystalline peptide suspensions |
| 08/29/2006 | US7098246 Esterified hydroxytyrosol; 2-(3,4-dihydroxyphenyl)ethyl acetate for example |
| 08/29/2006 | US7098230 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/29/2006 | US7098216 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/29/2006 | US7098207 Imidazotriazinones and the use thereof |
| 08/29/2006 | US7098193 Useful for the treatment of gastrointestinal conditions |
| 08/29/2006 | US7098190 Formulations comprising antisense nucleotides to connexins |
| 08/29/2006 | US7098032 Delivering a nucleic acid to a cell; condensing nucleic acid with polyampholyte to complex; crosslinking polyampholyte; contacting with cell; gene therapy |
| 08/29/2006 | US7098028 Preparing in vitro cell cultures utilizing self assembling macroscopic membranes for use as slow-diffusion drug delivery systems, artificial skin, separation matrices and animal model for alzheimer's and viral diseases |
| 08/29/2006 | US7097971 novel peptides based on conserved regions of regulatory and auxiliary HIV proteins, antigens in free or carrier-bound form comprising one of the peptides, vaccine compositions containing one of the antigens, immunoassay kits and a method of detecting antibodies, induced by HIV using such antigens |
| 08/29/2006 | US7097868 Stable coated microcapsules |
| 08/29/2006 | US7097864 topical or transdermal anlgesics comprising extracts from shrubs and herbs, glutamine and fat soluble ascorbyl palmitate in the form of vitamin c; antiinflammatory agents |
| 08/29/2006 | US7097857 Methods and compositions for the targeted delivery of biologically active agents |
| 08/29/2006 | US7097856 Dendrimeric support or carrier macromolecule |
| 08/29/2006 | US7097855 in situ addition polymerization of water soluble, biocompartible and biodegradable acrylic polymers, for drug delivery in tissue engineering |
| 08/29/2006 | US7097854 Amino alcohol derivatives, process for their production and pharmaceutical preparations and reagents containing these compounds |
| 08/29/2006 | US7097853 drug delivery devices comprising backings and pressure sensitive adhesives comprising copolymers containing drugs |
| 08/29/2006 | US7097852 Solution comprising sea water as expectorant and virucidal for the treatment of respiratory diseases and method to use and develop |
| 08/29/2006 | US7097851 Multilayer capsule comprises an adhesion site-controlling layer for attaching to a selected site in the intestines, a drug-carrying layer, a protecting layer for preventing from digestive juice; improve bioavailability due to a low absorption in the digestive tract; dosage forms |
| 08/29/2006 | US7097849 Injectable aqueous dispersions of propofol |
| 08/29/2006 | US7097827 Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments |
| 08/29/2006 | US7097775 Coated microfluidic delivery system |
| 08/29/2006 | CA2411918C Cubic liquid crystalline compositions and methods for their preparation |
| 08/29/2006 | CA2402020C Pharmaceutical compositions |
| 08/29/2006 | CA2394290C Release of lipophilic active agents from chewing gum |
| 08/29/2006 | CA2342390C Sustained release ranolazine formulations |
| 08/29/2006 | CA2342340C New sustained release oral formulations |
| 08/29/2006 | CA2314934C Use of microparticles combined with submicron oil-in-water emulsions |
| 08/29/2006 | CA2281684C Inhibition of cell-cell binding by lipid assemblies |
| 08/29/2006 | CA2277914C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide |
| 08/29/2006 | CA2277891C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof |
| 08/29/2006 | CA2277890C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising formoterol |
| 08/29/2006 | CA2271306C Pharmaceutical suspension systems |
| 08/29/2006 | CA2270177C Transdermal administration of ment |
| 08/29/2006 | CA2255564C Aerodynamically light particles for pulmonary drug delivery |
| 08/29/2006 | CA2247198C Topical pharmaceutical composition containing heparin |
| 08/29/2006 | CA2243863C Gastrointestinal drug delivery system |
| 08/29/2006 | CA2213996C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 08/29/2006 | CA2211874C Carrier particles for use in dry powder inhalers |
| 08/29/2006 | CA2131515C Effervescent mixture with alkali metal salts or lysinates of acidic, insoluble or slightly soluble active ingredients |
| 08/25/2006 | CA2534602A1 Water-in-oil type micro-emulsion |
| 08/24/2006 | WO2006089245A2 Bubble architectures and methods of making and using thereof |
| 08/24/2006 | WO2006089070A2 Acne gel |
| 08/24/2006 | WO2006088864A1 Controlled release compositions comprising levetiracetam |
| 08/24/2006 | WO2006088647A1 Polymer particle delivery compositions and methods of use |
| 08/24/2006 | WO2006088487A2 Permanently linked, magnetic chains |
| 08/24/2006 | WO2006088473A2 Microcapsules and nanocapsules for the transmucosal delivery of therapeutic and diagnostic agents |
| 08/24/2006 | WO2006088305A1 Gastric-retentive controlled release mono-matrix tablet |
| 08/24/2006 | WO2006088245A1 Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative |
| 08/24/2006 | WO2006088134A1 Method of relieving or avoiding side effect of steroid compound |
| 08/24/2006 | WO2006087968A1 Solid ophthalmic drug for external use |
| 08/24/2006 | WO2006087919A1 Finely divided composition containing poorly water soluble substance |
| 08/24/2006 | WO2006087639A1 Composition comprising ocaperidone |
| 08/24/2006 | WO2006087629A2 Rapidly disintegrating composition of olanzapine |
| 08/24/2006 | WO2006087395A1 Multimicroparticulate oral pharmaceutical form with modified release of angiotensin ii receptor antagonists |
| 08/24/2006 | WO2006087394A1 Oral pharmaceutical for of losartan |
| 08/24/2006 | WO2006087369A1 Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using them |
| 08/24/2006 | WO2006087358A2 Composition for adjusting water quality for administration of water sanitizer sensitive medicaments or vaccines |
| 08/24/2006 | WO2006087312A1 Tablets comprising a biologically active substance and an excipient containing calcium carbonate |
| 08/24/2006 | WO2006087233A2 Release of extracellular membrane particles carrying the stem cell marker prominin-1 (cd133) from neural progenitors and other epithelial cells |
| 08/24/2006 | WO2006087164A1 Compositions containing polysaccharides |
| 08/24/2006 | WO2006087160A1 Method for a treatment with a medicament combination and medicament combinations suitable for the same |
| 08/24/2006 | WO2006087156A1 Nanoemulsions comprising lipoaminoacids and monoglycerides, diglycerides and polyglycerides of fatty acids |
| 08/24/2006 | WO2006087116A1 Oral dosage form comprising rosiglitazone |
| 08/24/2006 | WO2006087028A1 Composition containing chitosan for sustained drug release |
| 08/24/2006 | WO2006087027A1 Partly neutralised anionic (meth)acrylate copolymer |
| 08/24/2006 | WO2006086864A1 Pharmaceutical compositions comprising aromatic solubilizing agents |
| 08/24/2006 | WO2006086856A1 Combination therapeutic compositions and method of use |
| 08/24/2006 | WO2006072888A3 Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis |
| 08/24/2006 | WO2006067600A3 Herbal formulations as cough lozenge |
| 08/24/2006 | WO2006067599A3 Stable oral benzimidazole compositions and process of preparation thereof |
| 08/24/2006 | WO2006066317A8 Controlled release of biological entities |
| 08/24/2006 | WO2006065722A3 Compositions and methods for pulmonary conditions |
| 08/24/2006 | WO2006065432A3 Nanoparticles for delivery of therapeutic agents using ultrasound and associated methods |
| 08/24/2006 | WO2006062655A3 Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4] triazol-1-yl}-1h-pyrrolo[2,3-c]pyridin-3-yl}-ethane-1,2-dione |
| 08/24/2006 | WO2006061340A3 Stable, hormone-containing (intermediate) product |
| 08/24/2006 | WO2006061156A3 Medicament for hygienic application inside the ear |
| 08/24/2006 | WO2006060325A3 Coated drug delivery formulations |
| 08/24/2006 | WO2006056204A8 Method of cross-linking hyaluronic acid with divinylsulfone |
| 08/24/2006 | WO2006054307A3 Controlled absorption of statins in the intestine |
| 08/24/2006 | WO2006053089A3 Methods and formulations for making pharmaceutical compositions containing bupropion |
| 08/24/2006 | WO2006051406A3 Over dosage indicating medicated film strip |
| 08/24/2006 | WO2006041843A3 Pharmaceutical dosage form comprising meloxicam |
| 08/24/2006 | WO2006033713A3 Methods for ciprofloxacin inhalation |
| 08/24/2006 | WO2006032958A3 Composition in micro-pellets with controlled release physiologically active substance, procedure for their preparation and use in the zootechenical sector |
| 08/24/2006 | WO2006029074A3 Methods for transmembrane treatment and prevention of otitis media |
| 08/24/2006 | WO2006024944A3 Pharmaceutical dosage forms comprising a low-solubility drug and a polymer |
| 08/24/2006 | WO2006018814A3 Oral liquid suspensions of metaxalone |
| 08/24/2006 | WO2006015154A3 Compositions and methods for nutrition supplementation |